How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hypertension-with-left-ventricular-hypertrophy.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hypertension with Left Ventricular Hypertrophy — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypertension with Left Ventricular Hypertrophy (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypertension with Left Ventricular Hypertrophy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cozaar	losartan	Merck & Co.	ARB (Angiotensin II receptor blocker)	AT1 receptor	1995-04-14
Cozaar	LOSARTAN POTASSIUM	Merck & Co.	Angiotensin 2 Receptor Blocker	Type-1 angiotensin II receptor	1995-01-01
Microzide	hydrochlorothiazide	Generic (originally Merck)	Thiazide Diuretic [EPC]	ACE	1959-01-01
Diuril	CHLOROTHIAZIDE	Salix Pharms	Thiazide Diuretic	Solute carrier family 12 member 3	1958-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Merck & Co. · 2 drugs in Hypertension with Left Ventricular Hypertrophy
Generic (originally Merck) · 1 drug in Hypertension with Left Ventricular Hypertrophy
Salix Pharms · 1 drug in Hypertension with Left Ventricular Hypertrophy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypertension with Left Ventricular Hypertrophy:

Cite this brief

Drug Landscape (2026). Hypertension with Left Ventricular Hypertrophy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypertension-with-left-ventricular-hypertrophy. Accessed 2026-06-10.

Hypertension with Left Ventricular Hypertrophy full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing